Ownership history in FCPM III SERVICES B.V. · 9 quarters on record
This page tracks every 13F SEC filing in which FCPM III SERVICES B.V. reported a position in NEWAMSTERDAM PHARMA COMPANY (NAMS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 9,198,900 | -13,484 | -0.1% | 42.30% | $322.7M | $35.08 |
| 2025 Q3 | REDUCED | 9,212,384 | -1,419,729 | -13.4% | 52.36% | $262.0M | $28.44 |
| 2025 Q2 | REDUCED | 10,632,113 | -303,197 | -2.8% | 52.16% | $192.5M | $18.11 |
| 2025 Q1 | ADDED | 10,935,310 | +338,129 | +3.2% | 54.11% | $223.8M | $20.47 |
| 2024 Q4 | REDUCED | 10,597,181 | -1,234,280 | -10.4% | 45.97% | $272.3M | $25.70 |
| 2024 Q3 | UNCHANGED | 11,831,461 | — | 0% | 33.73% | $196.4M | $16.60 |
| 2024 Q2 | UNCHANGED | 11,831,461 | — | 0% | 33.52% | $227.3M | $19.21 |
| 2024 Q1 | UNCHANGED | 11,831,461 | — | 0% | 39.56% | $279.8M | $23.65 |
| 2023 Q4 | INITIATED | 11,831,461 | — | — | 38.94% | $132.2M | — |
As of 2025 Q4 — sorted by position size